MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Avanos Medical Total Assets 2011-2026 | AVNS
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.07 B | 1.15 B | 1.69 B | 1.79 B | 1.6 B | 1.67 B | 1.8 B | 1.83 B | 2.2 B | 2.07 B | 2 B | 2.53 B | 2.48 B | 2.53 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.53 B | 1.07 B | 1.89 B |
Quarterly Total Assets Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.07 B | 1.04 B | 1.11 B | 1.15 B | 1.66 B | 1.66 B | 1.66 B | 1.69 B | 1.72 B | 1.67 B | 1.73 B | 1.79 B | 1.78 B | 1.75 B | 1.77 B | 1.6 B | 1.6 B | 1.68 B | 1.65 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.8 B | 1.8 B | 1.8 B | 1.8 B | 1.83 B | 1.83 B | 1.83 B | 1.83 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.07 B | 2.07 B | 2.07 B | 2.07 B | 2 B | 2 B | 2 B | 2 B | 2.52 B | 2.53 B | 2.53 B | 2.53 B | 2.48 B | 2.48 B | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.53 B | 1.04 B | 1.86 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 13.11 | 0.23 % | $ 1.77 B |  USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 25.71 | 2.43 % | $ 217 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.32 | 0.3 % | $ 124 M |  France |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.18 | 8.12 % | $ 317 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.04 | 3.03 % | $ 1.24 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.61 | -4.04 % | $ 38 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 56.14 | 5.11 % | $ 1.65 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 60.1 | 2.0 % | $ 3.28 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.06 | 2.87 % | $ 353 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.79 | -2.64 % | $ 1.01 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 90.18 | 2.72 % | $ 12.2 B | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.38 | 1.67 % | $ 372 M | USA |
 |
NanoVibronix
NAOV
|
41.1 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.66 | 1.95 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 88.51 | 5.78 % | $ 3.07 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 83.5 | 2.81 % | $ 48.8 B | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.23 | -2.97 % | $ 62.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.28 | 6.67 % | $ 52.1 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.36 | 8.91 % | $ 497 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.86 | 8.54 % | $ 36 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
NuVasive
NUVA
|
2.22 B | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |
 |
Natus Medical Incorporated
NTUS
|
564 M | - | 1.94 % | $ 1.05 B | USA |